Trademark Overview
On Friday, August 30, 2024, a trademark application was filed for BIVRETH with the United States Patent and Trademark Office. The USPTO has given the BIVRETH trademark a serial number of 98725903. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, February 6, 2025. This trademark is owned by GLAXO GROUP LIMITED. The BIVRETH trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders